https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
The diagnosis of asymptomatic cardiac myxoma was present in 28.4% of patients, with an increasing trend for incidence over the years. This is possibly due to increased opportunistic screening (with electrocardiogram and clinical examination) as well as higher usage of medical imaging.INTRODUCTION Stroke is a leading cause of death and disability, with the administration of reverse transcriptase-plasminogen activator (rtPA) improving outcomes in a time-dependent manner. Only 52.3% of our eligible stroke patients received rtP
Mi piace
Commento
Condividi
